Background: Acupuncture has been using as an alternative non-pharmacological therapy in the management of post stroke depression and cognitive impairment but its effectiveness and safety remain controversial. We conducted an overview of systematic reviews with meta-analyses to evaluate the evidence on the effect of acupuncture in the treatment of stroke with conventional medicine intervention. Methods: Systematic reviews summarized the treatment effects of acupuncture for post stroke cognitive impairment and post stroke depression were considered eligible. Methodological quality of included systematic reviews was assessed using A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR 2). Results: Four systematic reviews on post stroke cognitive impairment and ten systematic reviews on post stroke depression with good methodological quality were included. Meta-analyses revealed that acupuncture plus cognitive rehabilitation; and acupuncture or moxibustion plus cognitive rehabilitation, versus cognitive rehabilitation demonstrated statistically significant increase in Mini-Mental State Examination scores in compared to cognitive rehabilitation after 4 weeks treatment [Pooled weighted mean difference (WMD) = 3.14, 95% confidence interval (CI) = 2.06 to 4.21, I2 = 36%]; and (Pooled WMD = 3.22, 95% CI = 2.09 to 4.34, I2 = 0%). Furthermore, acupuncture versus antidepressant demonstrated statistically significant improve depression measured by increasing in 17-item Hamilton Depression Rating Scale in comparing to cognitive rehabilitation after 2 weeks treatment (Pooled WMD= -2.34, 95% CI= -3.46 to -1.22, I2 = 5%). Acupuncture usage was not associated with increased risk of adverse events. Conclusions: Acupuncture is safe and improves cognitive function and depressive disorder without obvious serious adverse events for post stroke patients.
Introduction
Incident stroke could lead to emotional changes and an acute decline in cognitive function. 1, 2 The emotional changes after stroke are thought to result from disruption of prefrontal system and lesions damaging the striato-pallido-thalamo-cortical pathways [3] [4] [5] while the decline in cognitive function after stroke is due to the reduction of regional blood flow blocked by recurrent and multiple infarctions. 6 Post stroke depression (PSD) is associated with poor functional outcomes, and consistently high mortality rates 7, 8 and post-stroke cognitive impairment is associated with increase mortality, 9 hospitalization, 10 disability, 11 and poorer quality of life. 12 It has been found that cognitive performance was associated with symptoms of depression and with self-reported cognitive function on patient after stroke. 13 In the management of post stroke depression, it has been suggested that Selective Serotonin Reuptake Inhibitors (SSRIs) is the first line treatment. 8 It has been proven that SSRI (Fluoxetine) had lower rates of depression and better motor function as compared to the placebo group at 3 months. 14 Whereas, drug therapy of poststroke cognitive impairment remains unclear. 6 Currently, there are no evidence-based interventions that can successfully treat post-stroke cognitive decline. Alternatives therapy such as cognitive rehabilitation may be beneficial for enhancing their attention deficits and activities of daily living (ADL) immediately following less than 3 months and 6 months of treatment respectively. 15 However, there is still insufficient evidence and unclear effectiveness of cognitive rehabilitation for improving individuals cognitive function. 16, 17 Acupuncture has been using as an alternative nonpharmacological therapy that involves the insertion of needles into acupuncture points in the skin as to correct imbalances of the flow of Qi through meridians. 18 Preclinical evidence demonstrated that acupuncture associates with the potential of DNA methylation and histone modifications of brain-derived neurotropic factor in epigenetic mechanism that may produce antidepressant effect in animal study. 19, 20 Acupuncture incorporation with electrotherapy also improves cognitive function and synaptic plasticity 21 by attenuating left cortex, hippocampus, corpus striatum, and thalamus lesions and increasing the density of dendritic spines and number of CA1 synapse in the hippocampus of middle cerebral artery occlusion induced cognitive deficit rats. 22, 23 Many clinical studies have suggested the use of acupuncture in the management of post stroke depression [24] [25] [26] [27] [28] [29] [30] [31] [32] and cognitive impairment. [33] [34] [35] [36] [37] [38] These trials were implemented with different methodologies and outcome measures. The treatment effects of acupuncture on post-stroke cognitive impairment and depression were inconclusive from systematic reviews. [39] [40] [41] [42] Systematic reviews have been conducted to examine the potential relative benefits or harms of acupuncture in the treatment of post-stroke cognitive impairment and depression. However, the treatment benefits of acupuncture on post-stroke cognitive impairment and depression are still unclear due to the differences of methods, and quality of systematic reviews. We conduct an overview of systematic reviews to overcome the gaps by composing, appraising, and summarizing all relevant systematic reviews into a single document, which has potential usefulness for therapeutic and policy decision-making. Furthermore, there has been no overview of systematic reviews to analyze the effectiveness and safety of acupuncture for improving cognitive function and depression in post-stroke patient. In this overview of systematic reviews, we aim to summarize the best available clinical evidence on the effectiveness and safety of acupuncture on post-stroke cognitive impairment and depression management. This study will provide a comprehensive synthesis of clinical evidence on acupuncture on post-stroke cognitive impairment and depression receiving routine stroke care, which may help in identifying treatment alternatives with acupuncture on post-stroke cognitive impairment and depression management so as to provide a basis to develop an integrative medicine model for post-stroke cognitive impairment and depression.
Methods

Search strategy
A literature search of online databases MEDLINE, Excerpta Medica dataBASE (EMBASE), Cochrane Database of Systematic Reviews (CDSR) and Database of abstracts of reviews of effects (DARE) and Chinese databases [Chinese Biomedical Database (CBM), Wan Fang Digital journals and Taiwan Periodical Literature Databases] from inception to August 2017 was performed. Specialized search filter for reviews was used for MEDLINE and EMBASE. 43, 44 Detailed searching strategies were reported in Supplment 1.
Eligibility criteria
Types of studies
We included systematic reviews (SRs) with meta-analysis of randomized controlled trials (RCTs) in this overview. RCTs are trials that group patients by simple random methods. We excluded SRs with meta-analysis of observational studies, which included case-control studies, cross-sectional studies, longitudinal studies, and cohort studies. We used the Cochrane Collaboration definition for systematic review, that is a form of publication that searches, identifies, appraises, and collates all empirical evidence according to the pre-specified eligibility criteria to answer the objectives or specific research questions, using systematic methods to minimize risk of bias. 45 We only included the SRs that used validated method to measure the outcome. We evaluated all possible clinical evidence in the use of acupuncture versus conventional intervention for post-stroke cognitive impairment management and the use of acupuncture versus anti-depressant for post stroke depression treatment.
Subjects
We included patients diagnosed with any type of stroke by World Health Organization stroke criteria 46 (ischemic stroke, acute ischemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, acute stroke, progressive cerebral infarction, acute cerebral infarction, cerebral haemorrhage, and cerebral ischemic stroke) or America stroke association criteria 47 (ischemic, haemorrhagic, transient ischemic) and received acupuncture along with conventional intervention (cognitive rehabilitation and conventional therapy) in post-stroke management. The participants in the included reviews were not limited by gender, age, course of the disease, and treatment duration.
Intervention and control
We included peer-reviewed full articles published in English and Chinese language. Subjects were defined by a diagnosis of stroke 46, 47 and were using acupuncture and conventional intervention. Acupuncture included (needle) acupuncture, electroacupuncture, and moxibustion therapy. The specific types of (needle) acupuncture and moxibustion referred to 'Acupuncture and moxibustion law, 7th edition' as the selection criteria. 48 We included acupuncture interventions regardless of needle material, treatment points (e.g., single head acupuncture treatment or scalp), the implementation of techniques, selected points to implement the hands of time, leaving the needle time and treatment is not limited. Cognitive rehabilitation, which included physiotherapy, occupational therapy, speech therapy, and nursing care, was used in the management of post-stroke cognitive impairment. Conventional therapy included use of drugs, such as antiplatelet agents, anticoagulants, fibrinogen-depleting agents, and volume expansion and vasodilators, and neuroprotective agents; but not including thrombolytic agents. Conventional care also included treatment for stroke related complications, such as brain edema, seizures, dysphagia, pneumonia, voiding dysfunction and urinary tract infections, and deep vein thrombosis. Anti-depressants were included monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), tetracyclic antidepressants (TeCAs) and SSRIs for the treatment of post stroke depression. In the management of post-stroke cognitive impairment, two types of comparisons were considered to be included in this overview of SRs: (1) acupuncture plus cognitive intervention versus cognitive intervention only; and (2) acupuncture plus cognitive intervention versus placebo of acupuncture plus cognitive intervention.
For the treatment of post stroke depression, two types of comparisons were considered to be included in this overview of SRs: (1) acupuncture versus anti-depressant only; and (2) acupuncture versus placebo of acupuncture plus anti-depressant.
Selection of systematic reviews
Data extraction
We extracted the following data from full-text articles: (i) basic characteristics of the SRs, searching date of the study, number of included studies, total number of patients and bibliographic information; (ii) detail information on study design and patient, intervention, control and outcomes; (iii) meta-analysis results of the including pooled effects of each comparison for each outcome; and (iv) results of methodological quality assessment.
Quality assessment of systematic reviews
Methodological quality of all included SRs was assessed using Assessing the Methodological Quality of Systematic Reviews (AMSTAR 2). 49 The judgments were given in 11 items as 'yes', "no", "cannot answer" or "not applicable" based on the information provided. The detail description of AMSTAR 2 is provided in Table 2 . Two researchers conducted literature selection, data extraction and methodological quality assessment independently. Any disagreement was discussed with consensus. A third reviewer assessed unresolved discrepancy when necessary.
Data analyses
The acupuncture treatments were assessed at SRs level. The pool effect estimates were extracted from each meta-analyses. We extracted pooled relative risk (RR) or pooled odds ratio (OR) for dichotomous outcomes, and pooled weighted mean difference (WMD) for continuous outcomes with 95% confidence interval (CI). For publication bias, funnel plot results would be reported if it was being mentioned in the included SRs. Heterogeneity across RCTs was reported by describing I 2 values reported in included metaanalysis; I 2 values of 0-25%, 26-50%, and above 50% represented low, medium and high heterogeneity, respectively. 50 
Outcome
We evaluated all possible clinical evidence in the use of acupuncture along with conventional medicine intervention for post-stroke cognitive impairment and depression. Cognitive function and depressive disorder were the two major outcomes for evaluating the effectiveness of acupuncture. The primary clinical outcomes were cognitive function improvement and depression symptoms improvement. Cognitive function was assessed at the end of treatment course by Mini-Mental State Exam (MMSE). 51 Depression were assessed at the end of treatment course by Hamilton Rating Scale for Depression (HAMD). 52 We also reported on other outcomes, including ADL, 53 change of P300 amplitude, 54 change of P300 latency, 54 and change of neurobehavioral cognitive status examination 55 total scores, change of BI, 56 Mangled Extremity Severity Score (MESS) 57 reduction rate, change of Fugl-Meyer scales, 58 change of Sandoz clinical assessment geriatric scale, 59 change of functional independence measure, 60 and change of the antidepressant side-effect checklist. 61 
Results
Study characteristics
A total of 2305 citations were retrieved from the electronic databases, among which 14 SRs 42,62-74 fulfilled the inclusion criteria (Fig. 1 The percentage of male participants was ranged from 53.5% to 61.4% (from three SRs 64, 65, 73 ). The reported age of participants was ranged from 30 to 79 years (from two SRs 63, 64 ). The range of duration of disease since onset was ranged from 12 days to 1 year from one SR. 64 The treatment during of disease since onset was ranged from 2 to 24 weeks from thirteen SRs. 42, [62] [63] [64] [65] [66] [67] [69] [70] [71] [72] [73] [74] Four SRs 42,62-64 focused on post-stroke cognitive impairment and ten SRs [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] summarized the evidence on post stroke depression.
Methodological quality of included SRs
All SRs 42,62-74 performed comprehensive literatures search and evaluated the scientific quality of the included studies ( 
Outcome measures
The types of outcomes measures used across the SRs were summarized in Table 3 . Other reported outcomes were listed in Appendix II. Four (28.6%) SRs 42,62-64 provided meta-analytic results on cognitive function. Ten (71.4%) SRs [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] reported meta-analytic results on depression. plus cognitive rehabilitation versus cognitive rehabilitation demonstrated statistically significant increase in MMSE scores in compared to cognitive rehabilitation after 4 weeks treatment with medium heterogeneity (Pooled WMD = 3.14, 95% CI = 2.06 to 4.21, 4 RCTs, I 2 = 36%). 42 Acupuncture or moxibustion plus cognitive rehabilitation versus cognitive rehabilitation demonstrated statistically significant improvement in MMSE scores in compared to conventional stroke after 4 weeks treatment with low heterogeneity (Pooled WMD = 3.22, 95% CI = 2.09 to 4.34, 3 RCTs, I 2 = 0%). 63 Acupuncture or moxibustion plus cognitive rehabilitation versus cognitive rehabilitation or Nimodipin showed clinical benefit in MMSE scores improvement after 4-8 weeks treatment with low heterogeneity (Pooled WMD = 2.64, 95% CI = 1.78 to 3.50, 5 RCTs, I 2 = 0%). 63 Three SRs 42, 62, 64 studied the clinical effect of acupuncture, electro-acupuncture, or scalp acupuncture plus cognitive rehabilitation on post-stroke cognitive impairment. The clinical benefit of cognitive function improvement was inconclusive due to heterogeneity across the underlying studies. None of the four SRs 42,62-64 reported adverse events (AE) of acupuncture or moxibustion plus cognitive rehabilitation versus cognitive rehabilitation.
Post stroke depression
Ten SRs 65-74 evaluated the evidence of acupuncture for improvement of depression in post-stroke patient versus antidepressants. One SR 66 showed acupuncture versus antidepressants demonstrated statistically significant improve depression measured by increase in HAMD 17 items in compared to cognitive rehabilitation after 2 weeks treatment with low heterogeneity (Pooled WMD = −2.34, 95% CI = −3.46 to −1.22, 4 RCTs, I 2 = 5%). The clinical benefit of depression improvement from two SRs 67, 70 was inconclusive due to heterogeneity across the underlying studies and inclusion a single study result. Three SRs 66,67,69 measured HAMD 24 items reduction rate of acupuncture versus antidepressants in post-stroke patient. One SR 69 reported electroacupuncture versus antidepressants demonstrated statistically significant improvement in HAMD 24 items reduction rate after 8 weeks or 4 to 8 weeks of treatment with low heterogeneity (Pooled OR = 1.72, 95% CI = 1.05 to 2.28, 5 RCTs, I 2 = 0%) (Pooled OR = 1.61, 95% CI = 1.09 to 2.38, 12 RCTs, I 2 = 0%).
Eight SRs [65] [66] [67] [69] [70] [71] [72] 74 reported AE of acupuncture versus antidepressants. One SR 74 reported electro-acupuncture treatment was associated with fewer AEs in comparing to antidepressants (Pooled RR = 0.21, 95% CI = 0.14 to 0.33, 8 RCTs, I 2 = 0%). Two SRs 65, 70 showed acupuncture versus antidepressants demonstrated statistically significant reduction in the incidence of AE (Pooled RR = 0.32, 95% CI = 0.19 to 0.53, 8 RCTs, I 2 = 0%) (Pooled OR = 0.10, 95% CI = 0.05 to 0.19, 9 RCTs, I 2 = 42%) respectively. Five SRs 66, 67, 69, 71, 72 reported AE were described generally in SRs level. Most AE were reported in patients who received antidepressants which included dizziness, drowsiness, nausea, abnormal electrocardiogram, sweating, constipation, nausea, loss of appetite, abdominal pain, insomnia, elevated alanine aminotransferase, urinary retention, dry mouth, constipation, rash, and headache. The main AE from acupuncture group were soreness at the needle site, dizziness, sweating, gastrointestinal discomfort, skin allergy, and fatigue. None of these eight SRs [65] [66] [67] [69] [70] [71] [72] 74 showed that acupuncture usage would increase the risk of AE. No life-threatening adverse effects were noted in all these SRs.
3.5. Other outcomes 3.5.1. Post-stroke cognitive impairment One SR 42 reviewed acupuncture plus cognitive rehabilitation demonstrated significant benefit in improving cognitive functions measured by increase Neurobehavior Cognitive State Examination Total Score after 3-4 weeks of treatment with low heterogeneity (Pooled OR = 5.63, 95% CI = 3.95 to 7.31, 2 RCTs, I 2 = 0%). One SR 63 showed that acupuncture or moxibustion plus cognitive rehabilitation versus cognitive rehabilitation has significant benefit in improving functional disability measured by ADL after 4 weeks to 3 months treatment with medium heterogeneity (Pooled WMD = 0.52, 95% CI = 0.31 to 0.73, 6 RCTs, I 2 = 46%).
Three SRs 66,67,69 reviewed acupuncture or Electro-acupuncture versus antidepressants for improvement of depression measure by HAMD (24 items) reduction rate. Acupuncture versus antidepressants demonstrated statistically significant improvement in HAMD reduction rate after 1-8 weeks treatment with low heterogeneity (Pooled OR = 1.15, 95% CI = 1.07 to 1.24, 5 RCTs, I 2 = 24%). 67 This result was consistence another SR 66 which acupuncture versus Fluoxetine showed statistically significant improvement in HAMD reduction rate after 4 weeks treatment with low heterogeneity (Pooled OR = 1.11, 95% CI = 1.03 to 1.21, 8 RCTs, I 2 = 0%).
Electro-acupuncture versus Fluoxetine demonstrated statistically 
Discussion
To the best of our knowledge, this review is the first overview of systematic reviews to explore the efficacy and safety of acupuncture for the management of cognitive impairment and depression after stroke. The evidence compiled by this overview indicated that acupuncture in addition to conventional intervention could improve cognitive function. Furthermore, acupuncture can be more effective and safe than antidepressants in the treatment of post stroke depression.
Implication of practice
Our main aim in this study was to address the research evidence on acupuncture in post-stroke cognitive impairment and depression. We have conducted comprehensive searches of published reviews and electronic databases from both Chinese and English languages to minimize the potential publication bias and executed rigorous procedures for study selection, quality assessment and data extraction. The major practical contribution of our research is that it provides evidence for clinicians and policy makers to identify treatment alternatives with acupuncture in managing post-stroke cognitive impairment and depression. In the management of post-stroke cognitive impairment, it is been suggested that cognitive rehabilitation could be a treatment of choice. However, Cochrane Systematic Reviews have showed that cognitive rehabilitation can only demonstrate the treatment benefits in independent living, 75 and improving memory deficits. 76 Thus, acupuncture is demonstrated as a potential alternative intervention for treating post-stroke patient with cognitive impairment.
A second important implication of our study derives from our finding on the depression management by acupuncture. Antidepressants have been used for treating post stroke depression more than 30 years. Nortriptyline was the first antidepressants studied in patients with post stroke depression and showed significant clinical benefit in comparing to placebo for reducing HAMD scores over 6 weeks in 1984. 77 Ten years later, Citalopram, the first SSRI, was also demonstrated the clinical benefit of reducing HAMD scores over 6 weeks in patients with post stroke depression. 78 Have not said that, treatment with antidepressants is not without risk. Side effects associated with antidepressants can leads to premature drug discontinuation. For example, patients who take TCA could experience peripheral anticholinergic side effects, which are dry month, constipation, and urinary hesitancy. 79 Furthermore, SSRI use is associated with increased risk of hemorrhagic complications in elderly, 80, 81 and stroke, myocardial infarction, and all-cause mortality in postmenopausal women. 82 The potential common adverse events associated with acupuncture is transient which included fainting during treatment, nausea and vomiting, increased pain, diarrhea, local skin irritation, headaches, sweating, and dizziness. Using unused sterile needle could further prevent the transmission of infectious diseases. Acupuncture is potentially effective and safe monotherapy for post stroke depression.
Implication of research 4.2.1. Study design
It has been found that cognitive performance was associated with symptoms of depression and with self-reported cognitive function on patient after stroke 83 and there is strong association exiting between depression and the presence of cognitive deficits. 84 However, none of the included SRs studied the treatment benefits of acupuncture in post-stroke patients with both cognitive impairment and depression. Researcher should explore the potential treatment benefits in acupuncture for post-stroke patients with both cognitive impairment and depression. Furthermore, the treatment duration of all included SRs were below 24 weeks. The treatment benefits of acupuncture in post-stroke cognitive impairment and depression cannot be concluded in long-term treatment. In the future research, a consensus on study design and relevant outcome measures in conducting appropriate RCTs should be establishing in post-stroke cognitive impairment and depression management trials.
Study methodology
We did not cover Korean and Japanese database in our study. We are limited by our own language skills or ability to cover multicountries' database and to access potentially relevant studies in other language. It is advisable to form an international review teams to enhance the diversity of language resources and publication channels than a local teamwork.
There is room for improvement in methodological quality of the SRs. None of SR provided the protocol and list out all excluded and included studies. The included systematic reviews were not reported optimally. The outcome measures were generally poorly elaborated. Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) statement was not fully executed in the SRs; for instance, study characteristics, reporting risk of bias of individual studies and how it could affect publication and selection bias, and funding sources should be reported. Researchers should implement the reporting of RCTs following to the Consolidated Standards of Reporting Trials (CONSORT) statement to facilitate reliable, transparent and complete reporting of trials.
From the available evidence, acupuncture may be beneficial for improving cognitive function and depressive disorder without obvious serious adverse events for post-stroke patients in the convalescent stage. However, various limitations of the origanal studies, lack of methodological details, and insufficient reporting of trials hinder the strength of this recommendation and argue for further research to support this claim and implement changes to clinical practice.
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Cochrane database of systematic reviews (CDSR) from inception to 5 April 2019
No.
Searches Results Incident stroke could lead to emotional changes and an acute decline in cognitive function [1, 2] . The emotional changes after stroke is thought to result from disruption of prefrontal system and lesions damaging the striato-pallido-thalamo-cortical pathways [3] [4] [5] while the decline in cognitive function after stroke is due to the reduction of regional blood flow blocked by recurrent and multiple infarctions [6] . It has been found that cognitive performance was associated with symptoms of depression and with self-reported cognitive function on patient after stroke [7] . Although it has been suggested that Selective Serotonin Reuptake Inhibitors (SSRIs) is the first line treatment for post stroke depression [8] , there is still insufficient evidence and unclear effectiveness of cognitive rehabilitation for improving individuals cognitive function [9, 10] .
II Background and significance/preliminary studies Systematic reviews (SRs) with meta-analysis have also been conducted to examine the relative benefits or harms of acupuncture together with conventional medicine intervention in the treatment of cognitive impairment and depression. An overview of SRs with meta-analyses on acutpuncuture in post-stroke cognitive impairment and depression management can provide a concise summary of results from SRs, and is essential for overcoming the knowledge gaps by composing, appraising, and summarizing all critical information from individual SRs.
III Study aim
This study aims to provide an overview of the effectiveness and safety of different CHM for post-stroke management. With a comprehensive synthesis of clinical evidence on the add-on effect of CHM in routine stroke care, this study will provide support to evaluate the effectiveness of CHM in combination with conventional medicine intervention in stroke management. • We include SRs with meta-analysis of randomized controlled trials (RCTs) and quasi-randomized controlled trials in this overview.
• We exclude SRs with meta-analysis of observational studies, which include case-control studies, cross-sectional studies, longitudinal studies, and cohort studies.
• We use the Cochrane Collaboration definition for systematic review.
Subjects
• We include patients diagnosed with any type of stroke by World Health Organization stroke criteria [11] (ischemic stroke, acute ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, acute stroke, progressive cerebral infarction, acute cerebral infarction, cerebral hemorrhage, and cerebral ischemic stroke), or American Stroke Association criteria [12] (ischemic, hemorrhagic, transient ischemic) and received acupuncture along with conventional intervention (cognitive rehabilitation and conventional therapy) in post-stroke management.
• The subjects in the included reviews are not limited by gender, age, course of the disease, and treatment duration.
Intervention and control
• We include peer-reviewed full articles published in English and Chinese language.
• Subjects are using were using acupuncture and conventional intervention.
• Acupuncture included (needle) acupuncture, electroacupuncture, and moxibustion therapy. The specific types of (needle) acupuncture and moxibustion referred to 'Acupuncture and moxibustion law, 7th edition' as the selection criteria [13] .
• We include acupuncture interventions regardless of needle material, treatment points (e.g., single head acupuncture treatment or scalp), the implementation of techniques, selected points to implement the hands of time, leaving the needle time and treatment is not limited. The judgments are given in 11 items as "yes", "no", "cannot answer" or "not applicable" based on the information provided. e. Data collection process 1. Two researchers (CYFH and XYW) conduct literature selection, data extraction and methodological quality assessment independently. Any disagreement will be discussed with consensus. A third reviewer (VCHC) will assess unresolved discrepancy when necessary. f. Data items and synthesis 1. The acupuncture treatments are assessed at SRs level. 2. The pool effect estimates are extracted from each metaanalyses. 3. We extract pooled relative risk (RR) or pooled odds ratio (OR) for dichotomous outcomes, and pooled weighted mean difference (WMD) for continuous outcomes with 95% confidence interval (CI). Heterogeneity across RCTs is reported by describing I 2 values reported in included meta-analysis; I 2 values of 0-25%, 26-50%, and above 50% represented low, medium and high heterogeneity, respectively [16] .
Outcomes and prioritization
• The primary clinical outcomes are cognitive function improvement and depression symptoms improvement.
• Cognitive function is assessed at the end of treatment course by MMSE [17] . Depression were assessed at the end of treatment course by Hamilton Rating Scale for Depression (HAMD) [18] .
• All adverse events will be reported.
• We also report on other outcomes, including activity of daily living, change of Barthel index, Change of Mini-mental state examination, change of Fugl-Meyer scales in this paper.
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